Showing results (1211-1220 of 1,252) with videos related to

Sort By:
Pageof 126
BMJ Open|April 25, 2025
Mean arterial pressure after out-of-hospital cardiac arrest (METAPHORE): study protocol for a multicentre controlled trial with blinded primary outcome assessorNicolas Chudeau, Patrick Saulnier, Elsa Parot-Schinkel, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase InhibitorKyle Parcella, Tao Wang, Kyle Eastman, et al.
Diabetes & Metabolism|May 24, 2026
Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease - the ACTIDIANE randomized controlled trialSamy Hadjadj, Stéphanie Ragot, Lisa Durocher, et al.
Diabetes, Obesity & Metabolism|October 14, 2020
Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO studySarra Smati, Blandine Tramunt, Matthieu Wargny, et al.
Journal of Medicinal Chemistry|September 2, 2005
Discovery of a (1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activityMark Wittman, Joan Carboni, Ricardo Attar, et al.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Nature Medicine|July 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trialFernanda Mosele, Elise Deluche, Amelie Lusque, et al.
Diabetes & Metabolism|December 14, 2020
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19Jean-Daniel Lalau, Abdallah Al-Salameh, Samy Hadjadj, et al.
The Lancet. Neurology|June 5, 2012
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trialCaroline Moreau, Arnaud Delval, Luc Defebvre, et al.
Journal of Medicinal Chemistry|September 26, 2009
Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical developmentMark D Wittman, Joan M Carboni, Zheng Yang, et al.
Pageof 126